-
1
This study conducted a bibliometric analysis of short-chain fatty acids (SCFAs) in cognitive impairment, revealing key research trends and contributors.
-
2
A total of 425 articles from WoSCC and 514 from Scopus were analyzed, showing a continuous increase in publications from 2009 to 2025.
-
3
China was identified as the leading contributor to SCFA-related cognitive impairment research, with Wenzhou Medical University as a core collaboration hub.
-
4
High-frequency keywords included 'gut microbiota,' 'Alzheimer’s disease,' and 'neuroinflammation,' highlighting core themes in the research.
-
5
The study identified emerging research frontiers such as 'drug therapy,' 'microbiology,' and 'chemistry' related to SCFAs and cognitive impairment.
